Valuation: DBV Technologies

Market Cap 50Cr 56Cr 46Cr 42Cr 79Cr 5.38TCr 80Cr 555.83Cr 217.44Cr 2.74TCr 208.85Cr 204.25Cr 8.79TCr P/E 2026 *
-4.1x
P/E 2027 * -11.6x
Enterprise Value 43Cr 48Cr 40Cr 36Cr 69Cr 4.65TCr 69Cr 480.72Cr 188.06Cr 2.37TCr 180.63Cr 176.65Cr 7.61TCr EV / Sales 2026 *
119x
EV / Sales 2027 * 6.06x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day-0.65%
1 week-11.87%
Current month-19.09%
1 month-28.84%
3 months-41.12%
6 months-53.13%
Current year-50.36%
1 week 1.68
Extreme 1.678
1.9
1 month 1.68
Extreme 1.678
2.29
Current year 1.68
Extreme 1.678
4.4
1 year 1.68
Extreme 1.678
4.5
3 years 0.51
Extreme 0.506
4.5
5 years 0.51
Extreme 0.506
9.88
10 years 0.51
Extreme 0.506
86.64
Manager TitleAgeSince
Chief Executive Officer 66 29/11/2018
Director of Finance/CFO 56 06/11/2023
Chief Operating Officer - 01/12/2023
Director TitleAgeSince
Director/Board Member 51 21/10/2015
Director/Board Member 63 21/06/2016
Director/Board Member 60 15/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
29/07/26 Sell

Chief Technology Officer

-464 0.0002%
29/01/26 Sell

Chief Technology Officer

534 0.0003%
12/01/26
Baker Bros. Advisors LP
ExerciceCompany 5,46,09,792 27.1991%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-11.87%-40.50%-29.85% 56Cr
+0.83%+3.19%+37.87%+106.25% 1,05100Cr
+1.93%+2.11%+36.82%+64.90% 63TCr
+1.49%+5.19%+19.84%+85.41% 49TCr
+2.26%+0.90%+66.40%+39.33% 36TCr
+1.45%+3.50%+21.87%+42.64% 34TCr
+1.17%+2.37%+11.71%+35.14% 27TCr
+0.89%+1.08%-7.28%+10.52% 25TCr
+1.82%+2.94%+40.43%+52.78% 22TCr
+2.77%+4.44%+29.49%+101.40% 19TCr
Average +1.40%+1.09%+21.67%+50.85% 38.04TCr
Weighted average by Cap. +1.47%+2.44%+31.56%+69.95%

Financials

2026 *2027 *
Net sales 36L 40.32L 33.46L 30.46L 57.47L 39Cr 57.7L 4.03Cr 1.58Cr 20Cr 1.51Cr 1.48Cr 64Cr 6.23Cr 6.98Cr 5.79Cr 5.27Cr 9.94Cr 674.76Cr 9.98Cr 70Cr 27Cr 343.9Cr 26Cr 26Cr 1.1TCr
Net income -17Cr -20Cr -16Cr -15Cr -28Cr -1.89TCr -28Cr -195.03Cr -76Cr -962.1Cr -73Cr -72Cr -3.09TCr -13Cr -14Cr -12Cr -11Cr -20Cr -1.37TCr -20Cr -141.19Cr -55Cr -696.5Cr -53Cr -52Cr -2.23TCr
Net Debt -6.71Cr -7.52Cr -6.24Cr -5.68Cr -11Cr -726.99Cr -11Cr -75Cr -29Cr -370.52Cr -28Cr -28Cr -1.19TCr -12Cr -13Cr -11Cr -10Cr -19Cr -1.29TCr -19Cr -133.27Cr -52Cr -657.41Cr -50Cr -49Cr -2.11TCr
Projected Income Statement - Annual - DBV Technologies
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Date Price Change Volume
09/26/09 €1.678 -0.65% 5,94,470
08/26/08 €1.689 -4.90% 8,04,790
07/26/07 €1.776 +0.28% 13,75,248
06/26/06 €1.771 -4.58% 12,11,484
05/26/05 €1.856 -2.52% 12,26,325
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - DBV Technologies
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.678EUR
Average target price
3.637EUR
Spread / Average Target
+116.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DBV Technologies